Briracetam solution and preparation method thereof

By controlling the order and temperature of the additives of the auxiliary materials, the problem of poor solubility of the auxiliary materials in the briocetam solution is solved, and the stable preparation of briocetam solution is achieved, which improves clarity and stability and simplifies the production process.

CN118986873AActive Publication Date: 2024-11-22HAINAN WEI KANG PHARMA QIANSHAN
View PDF 16 Cites 0 Cited by

Patent Information

Application Number
CN202411132310.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-19
Publication Date
2024-11-22
Estimated Expiration
2044-08-19

AI Technical Summary

Technical Problem

During the preparation process, the brecetam solution has poor solubility in the water of the auxiliary materials, resulting in precipitation and stability problems. The aqueous solution is unstable and prone to degradation and impurities.

Method used

By controlling the order and temperature of the additives of the auxiliary materials, the preparation method includes mixing sodium carboxymethylcellulose with glycerol and mixing with purified water to form solution 1, then mixing with other auxiliary materials and components such as bralicetam, and stirring and filtering. A stable briocetam solution is obtained to ensure clarity and stability.

Benefits of technology

It improves the clarity and stability of the briocetam solution, avoids the generation of precipitation and degradation impurities, simplifies the production process, and improves the stability of oral liquids.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004998280040000071
    Figure BDA0004998280040000071
  • Figure BDA0004998280040000072
    Figure BDA0004998280040000072
  • Figure BDA0004998280040000081
    Figure BDA0004998280040000081
Patent Text Reader

Abstract

The invention discloses a preparation method of a briracetam solution and the briracetam solution, and belongs to the technical field of medicines. The preparation method of the briracetam solution comprises the following steps: (1) preparation of a solution 1: mixing a mixture containing sodium carboxymethyl cellulose and glycerol with purified water, and stirring to obtain the solution 1; (2) preparation of a solution 2: mixing and stirring purified water, methylparaben, sodium malate, malic acid, sucralose, a crystalline sorbitol solution, briracetam and glycerol to obtain an intermediate solution, and mixing and stirring the intermediate solution and essence to obtain the solution 2; and (3) mixing the solution 1, the solution 2 and purified water, stirring, and filtering to obtain the briracetam solution. According to the method, the clarity of the solution is improved by controlling the adding sequence, adding temperature and the like of all the auxiliary materials, and the obtained briracetam solution is good in stability and free of precipitates and degraded impurities.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to a preparation method of a brivaracetam solution and the brivaracetam solution thereof, and belongs to the field of medical technology. Background Art

[0002] Brivaracetam belongs to the third generation of anti-epileptic drugs and is a structural analogue of the anti-epileptic drug levetiracetam. As a third generation new AEDs, compared with previous AEDs, its mechanism of action is unique. Through high affinity for SV2A (synaptic vesicle protein 2A) and sodium ion channel inhibition, its anti-epileptic activity is significantly improved. Brivaracetam oral solution is an easy-to-use liquid dosage form, suitable for the treatment of partial-onset epilepsy in patients with epilepsy aged 16 years and above as an adjunct treatment.

[0003] In the preparation process of brivaracetam solution, some auxiliary materials are inevitably used. These auxiliary materials have poor solubility in water and are prone to precipitation after a period of time. In addition, the aqueous solution of brivaracetam is unstable, prone to degradation and impurities, and has poor stability. Summary of the invention

[0004] According to one aspect of the present application, a method for preparing a brivaracetam solution is provided. The method improves the clarity of the solution by controlling the addition order and addition temperature of each auxiliary material. The obtained brivaracetam solution has good stability and is free of precipitation and degradation impurities.

[0005] The preparation method of the brivaracetam solution described in the present application comprises the following steps:

[0006] (1) Preparation of solution 1: Mix a mixture including sodium carboxymethyl cellulose and glycerol I with purified water I, and stir to obtain solution 1;

[0007] (2) Preparation of solution 2: Mix purified water II, methylparaben, sodium malate, malic acid, sucralose, crystalline sorbitol solution, brivaracetam, and glycerol II, stir to obtain an intermediate solution, mix the intermediate solution and essence, stir to obtain solution 2;

[0008] (3) Solution 1, solution 2 and purified water III are mixed, stirred, and filtered to obtain a brivaracetam solution.

[0009] Optionally, the step (1) comprises: mixing sodium carboxymethyl cellulose and glycerol I, stirring I, then adding purified water I, and stirring II.

[0010] Optionally, in step (1), the stirring time of I is 25-35 min; preferably, in step (1), the stirring time of I is 30 min.

[0011] Optionally, in step (1), the stirring time of II is 10-20 min; preferably, the stirring time of II in step (1) is 15 min.

[0012] Optionally, the preparation temperature of the (1) solution 1 is 20-30°C.

[0013] Optionally, in the step (1), the weight ratio of sodium carboxymethyl cellulose to glycerol I is 1:(15-18); preferably, in the step (1), the weight ratio of sodium carboxymethyl cellulose to glycerol I is 1:16.5.

[0014] Optionally, in the step (1), the weight ratio of sodium carboxymethyl cellulose to purified water I is 1:(8-12); preferably, in the step (1), the weight ratio of sodium carboxymethyl cellulose to purified water I is 1:10.

[0015] Optionally, in step (2), the preparation temperature of the intermediate solution is 70-80°C; preferably, in step (2), the preparation temperature of the intermediate solution is 75°C.

[0016] Optionally, in step (2), the temperature at which the intermediate solution and the essence are mixed is 20-30°C; preferably, in step (2), the temperature at which the intermediate solution and the essence are mixed is 25°C.

[0017] Optionally, in the step (2), the weight ratio of purified water II, methylparaben and sucralose is (290-375):1:40; preferably, in the step (2), the weight ratio of purified water II, methylparaben and sucralose is 330:1:40.

[0018] Optionally, in the step (2), the weight ratio of the crystalline sorbitol solution, brivaracetam, glycerol II and methylparaben is (15-18):1:(6-8):0.1; wherein the crystalline sorbitol solution is calculated based on the sorbitol content; preferably, in the step (2), the weight ratio of the crystalline sorbitol solution, brivaracetam, glycerol II and methylparaben is 16.8:1:7:0.1, wherein the crystalline sorbitol solution is calculated based on the sorbitol content.

[0019] Optionally, in the step (2), the weight ratio of the essence to brivaracetam is (0.5-0.6):1; preferably, in the step (2), the weight ratio of the essence to brivaracetam is 0.53:1.

[0020] In the present application, sodium malate and malic acid are used to adjust the pH of the solution so that the pH of the final oral solution is 5.4.

[0021] Optionally, in step (3), the stirring time is 2-3 h; preferably, in step (3), the stirring time is 2 h.

[0022] Optionally, in step (3), the pore size of the filtration is 250-350 mesh; preferably, in step (3), the pore size of the filtration is 300 mesh.

[0023] Optionally, in the step (3), the weight ratio of purified water III to brivaracetam is (34-36):1; preferably, in the step (3), the weight ratio of purified water III to brivaracetam is 35:1.

[0024] Optionally, the weight ratio of sodium carboxymethyl cellulose to brivaracetam is 1:(1.5-2.5); preferably, the weight ratio of sodium carboxymethyl cellulose to brivaracetam is 1:2.

[0025] In another aspect, the present application provides a brivaracetam solution prepared by the preparation method of the brivaracetam solution.

[0026] The beneficial effects of this application include:

[0027] 1. The present application pre-disperses sodium carboxymethyl cellulose in a specified content of glycerol at 20-30° C. and then mixes it with a specified content of purified water, thereby improving the clarity of the brivaracetam solution, the clarity of which is less than 0.5, while reducing the dissolution time and avoiding the destruction of the structure of sodium carboxymethyl cellulose.

[0028] 2. In the present application, sodium carboxymethyl cellulose and glycerol are first mixed and dispersed, then mixed with purified water, and then mixed and stirred with solution 2. After this process, the dissolution process of carboxymethyl cellulose promotes the dissolution compatibility between the various auxiliary materials and avoids the generation of precipitation caused by the solubility of the auxiliary materials.

[0029] 3. The application pre-disperses sodium carboxymethylcellulose and glycerol at 20-30°C, and then mixes with purified water to obtain solution 1, and then methylparaben, purified water, glycerol, etc. are mixed to obtain solution 2, and solution 1 and solution 2 are mixed. This process solves the dissolution problem of sodium carboxymethylcellulose and methylparaben, and improves the stability of the oral liquid. It may be that sodium carboxymethylcellulose is present in glycerol with extremely small particles, and purified water is added later, so that the carboxymethylcellulose particles are quickly contacted with water molecules and dispersed. When the mixing of solution 1 and solution 2 in the later stage, the dispersion of materials such as methylparaben is promoted instead. In addition, the method simplifies the production process, and there is no need to dissolve methylparaben separately by glycerol, etc., and the methylparaben stability is high in the obtained oral liquid.

[0030] 4. The present application controls the addition ratio of purified water, methylparaben and glycerol in step (2), further improving the solubility of methylparaben in the brivaracetam solution and reducing the dissolution time of methylparaben.

[0031] 5. The process of the present application solves the problem of easy degradation and impurity generation of brivaracetam aqueous solution and has high stability.

[0032] 6. This application uses a 250-350 mesh filter membrane to filter the brivaracetam solution intermediate, and the filtration is smooth and there is no clogging. DETAILED DESCRIPTION

[0033] The present application is described in detail below with reference to embodiments, but the present application is not limited to these embodiments.

[0034] Unless otherwise specified, the raw materials in the examples of this application were purchased through commercial channels.

[0035] Example 1

[0036] Example 1 provides a method for preparing the brivaracetam solution, which is as follows:

[0037] (1) Preparation of solution 1: Mix sodium carboxymethyl cellulose and glycerol I at 25°C, stir for 30 min, then add purified water I and stir for 15 min;

[0038] (2) Preparation of Solution 2: Mix purified water II, methylparaben, sodium malate, malic acid, sucralose, crystalline sorbitol solution, brivaracetam, and glycerol II at 75°C and stir until completely dissolved; when the temperature drops to 25°C, add the flavor and stir until completely dissolved.

[0039] (3) Solution 1, solution 2 and purified water III were mixed, stirred for 2 h, and filtered (300 mesh).

[0040] In step (1), the added amounts of sodium carboxymethyl cellulose, glycerol I and purified water I are 1:16.5:10.

[0041] In step (2), the weight ratio of purified water II, methylparaben and sucralose is 330:1:40; the weight ratio of crystalline sorbitol solution, brivaracetam, glycerol II and methylparaben is 16.8:1:7:0.1, wherein the crystalline sorbitol solution is calculated based on the sorbitol content. The weight ratio of flavor and brivaracetam is 0.53:1.

[0042] Sodium malate and malic acid were used to adjust the pH of the final oral solution to 5.4.

[0043] In step (3), the weight ratio of purified water III to brivaracetam is 35:1.

[0044] In this embodiment, the amount of brivaracetam added is 10 g, and the amount of sodium carboxymethyl cellulose added is 5 g.

[0045] Comparative Example 1

[0046] Comparative Example 1 provides a method for preparing the brivaracetam solution, which is as follows:

[0047] 75 ℃, add 365g purified water, 1g methylparaben, sodium malate, malic acid, 5g sodium carboxymethyl cellulose, 40g sucralose in sequence, stir for 47min, stop heating and add 168g non-crystallized sorbitol solution (calculated as sorbitol), 10g brivaracetam, 152.5g glycerol in sequence, stir, add 5.3g flavor after the temperature drops to 25 ℃, then add 365 purified water, stir, and filter through a 300 mesh sieve.

[0048] The addition amount of each substance in Comparative Example 1 is the same as that in Example 1, and the addition amount of each material is the total amount of the corresponding substance addition amount in Example 1. Sodium malate and malic acid are used to adjust the pH so that the pH of the final oral solution is 5.4.

[0049] The solution obtained by this preparation method has poor clarity, with a clarity exceeding 0.5. The inventors speculate that the reason is that the structure of sodium carboxymethyl cellulose is damaged. However, the preparation process of Example 1 of the present application obtains a solution with a clarity of less than 0.5, which solves the problem of the damage to the structure of sodium carboxymethyl cellulose and reduces the dissolution time.

[0050] Comparative Example 2

[0051] A method for preparing a brivaracetam solution is as follows:

[0052] (1) Preparation of solution 1: At 25°C, mix 5 g of sodium carboxymethyl cellulose and 70 g of glycerol, stir for 30 min, then add 62.5 g of purified water and stir for 15 min;

[0053] (2) Preparation of Solution 2: Mix 317.5 g of purified water, 82.5 g of glycerin, 1 g of methylparaben, sodium malate, malic acid, 40 g of sucralose, 168 g of crystalline sorbitol solution (calculated as sorbitol), and 10 g of brivaracetam at 75° C., and stir until completely dissolved; when the temperature drops to 25° C., add 5.3 g of flavor, and stir until completely dissolved.

[0054] (3) Solution 1, Solution 2 and 350 g of purified water were mixed, stirred for 2 h, and filtered through a 300-mesh sieve.

[0055] Sodium malate and malic acid were used to adjust the pH of the final oral solution to 5.4.

[0056] The clarity of the brivaracetam oral solution obtained by the preparation method is poor, with a clarity greater than 0.5. The inventors speculate that this is caused by incomplete dissolution of sodium carboxymethyl cellulose and methylparaben, which proves that under the temperature and operating conditions determined in this application, the preparation process of Comparative Example 2 cannot meet the requirements.

[0057] Comparative Example 3

[0058] Comparative Example 3 provides a method for preparing the brivaracetam solution, which is as follows:

[0059] (1) Preparation of solution 1: At 25°C, mix 5 g of sodium carboxymethyl cellulose and 95 g of glycerol, stir for 30 min, then add 37.5 g of purified water and stir for 15 min;

[0060] (2) Preparation of Solution 2: Mix 342.5 g of purified water, 1 g of methylparaben, sodium malate, malic acid, 40 g of sucralose, 168 g of crystalline sorbitol solution (calculated as sorbitol), 10 g of brivaracetam, and 57.5 g of glycerol at 75° C., and stir until completely dissolved; when the temperature drops to 25° C., add 5.3 g of flavor, and stir until completely dissolved.

[0061] (3) Solution 1, Solution 2 and 350 g of purified water were mixed, stirred for 2 h, and filtered through a 300-mesh sieve.

[0062] Sodium malate and malic acid were used to adjust the pH of the final oral solution to 5.4.

[0063] The brivaracetam oral solution obtained by the preparation method has poor clarity, with a clarity greater than 0.5. After being placed for a period of time, there is a little sediment at the bottom. The inventor speculates that this is due to the poor compatibility between the various excipients.

[0064] Comparative Example 4

[0065] Comparative Example 4 provides a method for preparing a brivaracetam solution, and the specific implementation method is the same as that of Example 1, except that, step (1): preparation of solution 1: at 25° C., mix sodium carboxymethyl cellulose, glycerol and purified water and stir for 45 min.

[0066] The brivaracetam oral liquid obtained by the preparation method has extremely poor clarity, and after being left for a period of time, obvious precipitation is formed at the bottom.

[0067] Comparative Examples 2 to 4 prove that the present application requires that sodium carboxymethyl cellulose and a specified content of glycerol be first mixed, and then mixed with a specified content of purified water. At the same time, in the preparation process of solution 2, a specified content of glycerol is added, which solves the dissolution problem of sodium carboxymethyl cellulose and methylparaben and improves the stability of the oral solution. It may be that sodium carboxymethyl cellulose exists in glycerol as extremely small particles, and by adding purified water later, the carboxymethyl cellulose particles quickly contact the water molecules and disperse. When solution 1 and solution 2 are mixed later, the dispersion of materials such as methylparaben is promoted.

[0068] Comparative Example 5

[0069] Comparative Example 5 provides a method for preparing a brivaracetam solution, which is as follows:

[0070] (1) Preparation of solution 1: Mix 5 g of sodium carboxymethyl cellulose and 50 g of purified water at 25°C and stir for 45 min;

[0071] (2) Preparation of Solution 2: Mix 330 g of purified water, 1 g of methylparaben, sodium malate, malic acid, 40 g of sucralose, 168 g of crystalline sorbitol solution (calculated as sorbitol), 10 g of brivaracetam, and 152.5 g of glycerol at 75° C., and stir until completely dissolved; when the temperature drops to 25° C., add 5.3 g of flavor, and stir until completely dissolved.

[0072] (3) Solution 1, solution 2 and 350 g of pure water were mixed, stirred for 2 h, and filtered (300 mesh).

[0073] The clarity of the solution obtained by this method is still poor, with a clarity exceeding 0.5.

[0074] Comparative Example 6

[0075] Comparative Example 6 provides a method for preparing the brivaracetam solution, and its specific implementation method is the same as that of Example 1, except that the filtration pore size is different, as shown in Table 1.

[0076] Table 1

[0077]

[0078] From the test results in Table 1, it can be seen that the brivaracetam solution intermediate is subject to filtration risks when filtered through 1250-mesh, 625-mesh and 500-mesh filter membranes.

[0079] The stability of the brivaracetam solution obtained in Example 1 was tested under the following conditions: 60°C, naked exposure to light (5000 lx), and accelerated (40°C / 75% RH). The test results are shown in Table 2. Among them, methylparaben was determined by high performance liquid chromatography (Chinese Pharmacopoeia 2020 Edition Part IV General Rules 0512).

[0080] Table 2

[0081]

[0082]

[0083] The test results of reference preparation batch 350156 are shown in Tables 3 and 4.

[0084] Table 3

[0085]

[0086] Table 4

[0087]

[0088] Comparing Tables 2 to 4, it can be seen that the preparation method of the present application simplifies the operation process, and the obtained brivaracetam solution has good stability, which solves the dissolution problem of methylparaben and sodium carboxymethylcellulose.

[0089] The brivaracetam solution prepared in Example 1 was tested for related substances, and the test conditions were as follows: mobile phase A: 0.1% phosphoric acid aqueous solution; mobile phase B: acetonitrile, chromatographic column: Waters XBridge C18; detection wavelength was 210nm; mobile phase flow rate was 1.0ml / min; column temperature was 40°C; elution gradient was as follows:

[0090]

[0091]

[0092] The test results are shown in Table 5.

[0093] Table 5

[0094]

[0095] Impurity A: (R)-2-((R)-2-oxo-4-propylpyrrolidin-1-yl)butanamide; the structure is as follows:

[0096]

[0097] Impurity B: (S)-2-((S)-2-oxo-4-propylpyrrolidin-1-yl)butanamide; the structure is as follows:

[0098]

[0099] Impurity C: (R)-2-((S)-2-oxo-4-propylpyrrolidin-1-yl)butanamide; the structure is as follows:

[0100]

[0101] Impurity E: (2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butyric acid; the structure is as follows:

[0102]

[0103] The above are only a few embodiments of the present application and do not constitute any form of limitation to the present application. Although the present application is disclosed as above with preferred embodiments, it is not intended to limit the present application. Any technician familiar with the profession, without departing from the scope of the technical solution of the present application, using the technical content disclosed above to make slight changes or modifications are equivalent to equivalent implementation cases and fall within the scope of the technical solution.

Claims

1. A method for preparing a brivaracetam solution, characterized in that: The following steps are included: (1) Preparation of solution 1: Mix a mixture including sodium carboxymethyl cellulose and glycerol I with purified water I, and stir to obtain solution 1; (2) Preparation of solution 2: Mix purified water II, methylparaben, sodium malate, malic acid, sucralose, crystalline sorbitol solution, brivaracetam, and glycerol II, stir to obtain an intermediate solution, mix the intermediate solution and essence, stir to obtain solution 2; (3) Solution 1, solution 2 and purified water III are mixed, stirred, and filtered to obtain a brivaracetam solution.

2. The method for preparing the brivaracetam solution according to claim 1, characterized in that: The step (1) comprises: mixing sodium carboxymethyl cellulose and glycerol I, stirring I, then adding purified water I, and stirring II.

3. The method for preparing the brivaracetam solution according to claim 2, characterized in that: In the step (1), the stirring time of I is 25-35 min; Preferably, in step (1), the stirring time of II is 10-20 min.

4. The method for preparing the brivaracetam solution according to claim 1, characterized in that: The preparation temperature of the solution 1 is 20-30°C.

5. The method for preparing the brivaracetam solution according to claim 1, characterized in that: In the step (2), the preparation temperature of the intermediate solution is 70-80°C.

6. The method for preparing the brivaracetam solution according to claim 1, characterized in that: In the step (2), the temperature of the intermediate solution and the essence is 20-30°C.

7. The method for preparing the brivaracetam solution according to claim 1, characterized in that: In the step (3), the stirring time is 2-3 hours.

8. The method for preparing the brivaracetam solution according to claim 1, characterized in that: In the step (3), the pore size of the filtration is 250-350 mesh.

9. The method for preparing the liracetam solution according to any one of claims 1 to 8, characterized in that: In the step (1), the weight ratio of sodium carboxymethyl cellulose to glycerol I is 1:(15-18); Preferably, in step (1), the weight ratio of sodium carboxymethyl cellulose to purified water I is 1:(8-12); Preferably, in step (2), the weight ratio of purified water II, methylparaben and sucralose is (290-375):1:40; Preferably, in step (2), the weight ratio of the crystalline sorbitol solution, brivaracetam, glycerol II and methylparaben is (15-18):1:(6-8):0.1; wherein the crystalline sorbitol solution is calculated based on the sorbitol content; Preferably, in step (2), the weight ratio of flavor to brivaracetam is (0.5-0.6):1; Preferably, in step (3), the weight ratio of purified water III to brivaracetam is (34-36):1; Preferably, the weight ratio of sodium carboxymethyl cellulose to brivaracetam is 1:(1.5-2.5).

10. A brivaracetam solution prepared according to the method for preparing the brivaracetam solution according to any one of claims 1 to 9.

Citation Information

Patent Citations

  • Pharmaceutical solutions, process of preparation and therapeutic uses

    CN101945647A

  • Brivaracetam oral solution and preparation method thereof

    CN106491523A

  • Brivaracetam medicine solution and preparation method thereof

    CN113908120A

  • Preparation method of briracetam injection

    CN115364048A

  • Preparation and preparation method of brivaracetam oral liquid

    CN116265011A